CPT1C-positive cancer-associated fibroblast facilitates immunosuppression through promoting IL-6-induced M2-like phenotype of macrophage

References

• Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 2020;396(10251):635–12. doi:10.1016/S0140-6736(20)31288-5.
   PubMed Web of Science ®Google Scholar
• Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. doi:10.1186/s13045-023-01451-3.
   PubMed Web of Science ®Google Scholar
• Mortezaee K. Immune escape: a critical hallmark in solid tumors. Life Sci. 2020;258:118110. doi:10.1016/j.lfs.2020.118110.
   PubMed Web of Science ®Google Scholar
• Casals N, Zammit V, Herrero L, Fadó R, Rodríguez-Rodríguez R, Serra D. Carnitine palmitoyltransferase 1C: from cognition to cancer. Prog Lipid Res. 2016;61:134–148. doi:10.1016/j.plipres.2015.11.004.
   PubMed Web of Science ®Google Scholar
• Fadó R, Zagmutt S, Herrero L, Muley H, Rodríguez-Rodríguez R, Bi H, Serra D, Casals N. To be or not to be a fat burner, that is the question for cpt1c in cancer cells. Cell Death Disease. 2023;14(1):57. doi:10.1038/s41419-023-05599-1.
   PubMed Web of Science ®Google Scholar
• Chen T, Wu G, Hu H, Wu C. Enhanced fatty acid oxidation mediated by CPT1C promotes gastric cancer progression. J Gastrointest Oncol. 2020;11(4):695–707. doi:10.21037/jgo-20-157.
   PubMed Web of Science ®Google Scholar
• Gao J, Song J, Zhang Y, Zhu Z. CPT1C promotes the potential of gastric cancer ovarian metastasis through up-regulating fatty acid oxidation. Acta Biochim Biophys Sin (Shanghai). 2022;54(5):752–755. doi:10.3724/abbs.2022027.
   PubMed Web of Science ®Google Scholar
• Bu L, Baba H, Yoshida N, Miyake K, Yasuda T, Uchihara T, Tan P, Ishimoto T. Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment. Oncogene. 2019;38(25):4887–4901. doi:10.1038/s41388-019-0765-y.
   PubMed Web of Science ®Google Scholar
• Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. et al. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer. 2021;20(1):131. doi:10.1186/s12943-021-01428-1.
   PubMed Web of Science ®Google Scholar
• Ren G, Zhao X, Wang Y, Zhang X, Chen X, Xu C, Yuan Z-R, Roberts A, Zhang L, Zheng B. et al. CCR2-dependent recruitment of macrophages by tumor-educated mesenchymal stromal cells promotes tumor development and is mimicked by TNFα. Cell Stem Cell. 2012;11(6):812–824. doi:10.1016/j.stem.2012.08.013.
   PubMed Web of Science ®Google Scholar
• Gunaydin G. Cafs interacting with TAMs in tumor microenvironment to enhance tumorigenesis and immune evasion. Front Oncol. 2021;11:668349. doi:10.3389/fonc.2021.668349.
   PubMed Web of Science ®Google Scholar
• Lin Y, Xu J, Lan H. Tumor-associated macrophages in tumor metastasis: biological roles and clinical therapeutic applications. J Hematol Oncol. 2019;12(1):76. doi:10.1186/s13045-019-0760-3.
   PubMed Web of Science ®Google Scholar
• Chen Y, Song Y, Du W, Gong L, Chang H, Zou Z. Tumor-associated macrophages: an accomplice in solid tumor progression. J Biomed Sci. 2019;26(1):78. doi:10.1186/s12929-019-0568-z.
   PubMed Web of Science ®Google Scholar
• Ham IH, Lee D, Hur H. Role of cancer-associated fibroblast in gastric cancer progression and resistance to treatments. J Oncol. 2019;2019:6270784. doi:10.1155/2019/6270784.
   PubMed Web of Science ®Google Scholar
• Abe A, Nagatsuma AK, Higuchi Y, Nakamura Y, Yanagihara K, Ochiai A. Site-specific fibroblasts regulate site-specific inflammatory niche formation in gastric cancer. Gastric Cancer. 2017;20(1):92–103. doi:10.1007/s10120-015-0584-y.
   PubMed Web of Science ®Google Scholar
• Kim EK, Yoon SO, Jung WY, Lee H, Kang Y, Jang Y-J, Hong SW, Choi SH, Yang WI. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation. Gastric Cancer. 2017;20(3):438–447. doi:10.1007/s10120-016-0623-3.
   PubMed Web of Science ®Google Scholar
• Oh SC, Sohn BH, Cheong JH, Kim S-B, Lee JE, Park KC, Lee SH, Park J-L, Park Y-Y, Lee H-S. et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9(1):1777. doi:10.1038/s41467-018-04179-8.
   PubMed Web of Science ®Google Scholar
• Kim ST, Cristescu R, Bass AJ, Kim K-M, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–1458. doi:10.1038/s41591-018-0101-z.
   PubMed Web of Science ®Google Scholar
• Schwartz LH, Seymour L, Litiere S, Ford R, Gwyther S, Mandrekar S, Shankar L, Bogaerts J, Chen A, Dancey J, et al. RECIST 1.1 - standardisation and disease-specific adaptations: perspectives from the RECIST working group. Eur J Cancer. 2016;62:138–145. doi:10.1016/j.ejca.2016.03.082.
   PubMed Web of Science ®Google Scholar
• Kumar V, Ramnarayanan K, Sundar R, Padmanabhan N, Srivastava S, Koiwa M, Yasuda T, Koh V, Huang KK, Tay ST, et al. Single-cell atlas of lineage states, tumor microenvironment, and subtype-specific expression programs in gastric cancer. Cancer Discov. 2022;12(3):670–691. doi:10.1158/2159-8290.CD-21-0683.
   PubMed Web of Science ®Google Scholar
• Wang R, Song S, Qin J, Yoshimura K, Peng F, Chu Y, Li Y, Fan Y, Jin J, Dang M, et al. Evolution of immune and stromal cell states and ecotypes during gastric adenocarcinoma progression. Cancer Cell. 2023;41(8):1407–1426.e1409. doi:10.1016/j.ccell.2023.06.005.
   PubMed Web of Science ®Google Scholar
• Koncina E, Nurmik M, Pozdeev VI, Gilson C, Tsenkova M, Begaj R, Stang S, Gaigneaux A, Weindorfer C, Rodriguez F, et al. IL1R1(+) cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. Nat Commun. 2023;14(1):4251. doi:10.1038/s41467-023-39953-w.
   PubMed Web of Science ®Google Scholar
• Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202–209. doi:10.1038/nature13480.
   PubMed Web of Science ®Google Scholar
• Sohn BH, Hwang JE, Jang HJ, Lee HS, Oh SC, Shim JJ, Lee KW, Kim EH, Cheong JH, Jeong W, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23(15):4441–4449. doi:10.1158/1078-0432.CCR-16-2211.
   PubMed Web of Science ®Google Scholar
• Hou W, Ji Z, Chen Z, Wherry EJ, Hicks SC, Ji H. A statistical framework for differential pseudotime analysis with multiple single-cell RNA-seq samples. Nat Commun. 2023;14(1):7286. doi:10.1038/s41467-023-42841-y.
   PubMed Web of Science ®Google Scholar
• Zhang H, Yue X, Chen Z, Liu C, Wu W, Zhang N, Liu Z, Yang L, Jiang Q, Cheng Q, et al. Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials. Mol Cancer. 2023;22(1):159. doi:10.1186/s12943-023-01860-5.
   PubMed Web of Science ®Google Scholar
• Arpinati L, Scherz-Shouval R. From gatekeepers to providers: regulation of immune functions by cancer-associated fibroblasts. Trends Cancer. 2023;9(5):421–443. doi:10.1016/j.trecan.2023.01.007.
   PubMed Web of Science ®Google Scholar
• Timperi E, Romano E. Stromal circuits involving tumor-associated macrophages and cancer-associated fibroblasts. Front Immunol. 2023;14:1194642. doi:10.3389/fimmu.2023.1194642.
   PubMed Web of Science ®Google Scholar
• He L, Jhong JH, Chen Q, Huang KY, Strittmatter K, Kreuzer J, DeRan M, Wu X, Lee TY, Slavov N, et al. Global characterization of macrophage polarization mechanisms and identification of M2-type polarization inhibitors. Cell Rep. 2021;37(5):109955. doi:10.1016/j.celrep.2021.109955.
   PubMed Web of Science ®Google Scholar
• Murray PJ, Allen JE, Biswas SK, Fisher E, Gilroy D, Goerdt S, Gordon S, Hamilton J, Ivashkiv L, Lawrence T. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity. 2014;41(1):14–20. doi:10.1016/j.immuni.2014.06.008.
   PubMed Web of Science ®Google Scholar
• Wang Q, He Z, Huang M, Liu T, Wang Y, Xu H, Duan H, Ma P, Zhang L, Zamvil SS. et al. Vascular niche IL-6 induces alternative macrophage activation in glioblastoma through HIF-2α. Nat Commun. 2018;9(1):559. doi:10.1038/s41467-018-03050-0.
   PubMedGoogle Scholar
• Weng YS, Tseng HY, Chen YA, Shen P-C, Al Haq AT, Chen L-M, Tung Y-C, Hsu H-L. MCT-1/miR-34a/IL-6/IL-6R signaling axis promotes EMT progression, cancer stemness and M2 macrophage polarization in triple-negative breast cancer. Mol Cancer. 2019;18(1):42. doi:10.1186/s12943-019-0988-0.
   PubMed Web of Science ®Google Scholar
• Cho H, Seo Y, Loke KM, Kim SW, Oh SM, Kim JH, Soh J, Kim HS, Lee H, Kim J, et al. Cancer-stimulated CAFs enhance monocyte differentiation and protumoral TAM activation via IL6 and GM-CSF secretion. Clin Cancer Res. 2018;24(21):5407–5421. doi:10.1158/1078-0432.CCR-18-0125.
   PubMed Web of Science ®Google Scholar
• Fu XL, Duan W, Su CY, Mao F-Y, Lv Y-P, Teng Y-S, Yu P-W, Zhuang Y, Zhao Y-L. Interleukin 6 induces M2 macrophage differentiation by STAT3 activation that correlates with gastric cancer progression. Cancer Immunol Immunother. 2017;66(12):1597–1608. doi:10.1007/s00262-017-2052-5.
   PubMed Web of Science ®Google Scholar
• Narita Y, Muro K. Updated immunotherapy for gastric cancer. J Clin Med. 2023;12(7):12. doi:10.3390/jcm12072636.
   Web of Science ®Google Scholar
• Bensaad K, Favaro E, Lewis CA, Peck B, Lord S, Collins JM, Pinnick KE, Wigfield S, Buffa FM, Li JL, et al. Fatty acid uptake and lipid storage induced by HIF-1α contribute to cell growth and survival after hypoxia-reoxygenation. Cell Rep. 2014;9(1):349–365. doi:10.1016/j.celrep.2014.08.056.
   PubMed Web of Science ®Google Scholar
• Zaugg K, Yao Y, Reilly PT, Kannan K, Kiarash R, Mason J, Huang P, Sawyer SK, Fuerth B, Kalliomäki T, et al. Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev. 2011;25(10):1041–1051. doi:10.1101/gad.1987211.
   PubMed Web of Science ®Google Scholar
• Qu Q, Zeng F, Liu X, Wang QJ, Deng F. Fatty acid oxidation and carnitine palmitoyltransferase I: emerging therapeutic targets in cancer. Cell Death Disease. 2016;7(5):e2226. doi:10.1038/cddis.2016.132.
   PubMedGoogle Scholar
• Wang M, Wang K, Liao X, Hu H, Chen L, Meng L, Gao W, Li Q. Carnitine palmitoyltransferase system: a new target for anti-inflammatory and anticancer therapy? Front Pharmacol. 2021;12:760581. doi:10.3389/fphar.2021.760581.
   PubMed Web of Science ®Google Scholar
• Peng S, Li Y, Huang M, Tang G, Xie Y, Chen D, Hu Y, Yu T, Cai J, Yuan Z, et al. Metabolomics reveals that CAF-derived lipids promote colorectal cancer peritoneal metastasis by enhancing membrane fluidity. Int J Biol Sci. 2022;18(5):1912–1932. doi:10.7150/ijbs.68484.
   PubMed Web of Science ®Google Scholar
• Peng S, Chen D, Cai J, Yuan Z, Huang B, Li Y, Wang H, Luo Q, Kuang Y, Liang W, et al. Enhancing cancer-associated fibroblast fatty acid catabolism within a metabolically challenging tumor microenvironment drives colon cancer peritoneal metastasis. Mol Oncol. 2021;15(5):1391–1411. doi:10.1002/1878-0261.12917.
   PubMed Web of Science ®Google Scholar
• Chen X, Song E. Turning foes to friends: targeting cancer-associated fibroblasts. Nat Rev Drug Discov. 2019;18(2):99–115. doi:10.1038/s41573-018-0004-1.
   PubMed Web of Science ®Google Scholar
• Luo H, Xia X, Huang LB, An H, Cao M, Kim GD, Chen H-N, Zhang W-H, Shu Y, Kong X. et al. Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment. Nat Commun. 2022;13(1):6619. doi:10.1038/s41467-022-34395-2.
   PubMed Web of Science ®Google Scholar
• Chen Z, Zhou L, Liu L, Hou Y, Xiong M, Yang Y, Hu J, Chen K. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020;11(1):5077. doi:10.1038/s41467-020-18916-5.
   PubMed Web of Science ®Google Scholar
• Li X, Sun Z, Peng G, Xiao Y, Guo J, Wu B, Li X, Zhou W, Li J, Li Z. et al. Single-cell RNA sequencing reveals a pro-invasive cancer-associated fibroblast subgroup associated with poor clinical outcomes in patients with gastric cancer. Theranostics. 2022;12(2):620–638. doi:10.7150/thno.60540.
   PubMed Web of Science ®Google Scholar
• Barrett RL, Puré E. Cancer-associated fibroblasts and their influence on tumor immunity and immunotherapy. Elife. 2020;9. doi:10.7554/eLife.57243.
   PubMed Web of Science ®Google Scholar
• Desbois M, Wang Y. Cancer-associated fibroblasts: key players in shaping the tumor immune microenvironment. Immunol Rev. 2021;302(1):241–258. doi:10.1111/imr.12982.
   PubMed Web of Science ®Google Scholar
• Liu X, Yao L, Qu J, Liu L, Lu N, Wang J, Zhang J. Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression. J Transl Med. 2021;19(1):325. doi:10.1186/s12967-021-03012-z.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Chen T, Hu R, Zhu R, Li C, Ruan Y, Xie X, Li Y. Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomark Res. 2021;9(1):72. doi:10.1186/s40364-021-00327-3.
   PubMed Web of Science ®Google Scholar
• Gambardella V, Castillo J, Tarazona N, Gimeno-Valiente F, Martínez-Ciarpaglini C, Cabeza-Segura M, Roselló S, Roda D, Huerta M, Cervantes A. et al. The role of tumor-associated macrophages in gastric cancer development and their potential as a therapeutic target. Cancer Treat Rev. 2020;86:102015. doi:10.1016/j.ctrv.2020.102015.
   PubMed Web of Science ®Google Scholar
• Derks S, de Klerk LK, Xu X, Fleitas T, Liu KX, Liu Y, Dietlein F, Margolis C, Chiaravalli AM, Da Silva AC, et al. Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas. Ann Oncol. 2020;31(8):1011–1020. doi:10.1016/j.annonc.2020.04.011.
   PubMed Web of Science ®Google Scholar
• Kato T, Noma K, Ohara T, Kashima H, Katsura Y, Sato H, Komoto S, Katsube R, Ninomiya T, Tazawa H, et al. Cancer-associated fibroblasts affect intratumoral CD8(+) and FoxP3(+) T cells via IL6 in the tumor microenvironment. Clin Cancer Res. 2018;24(19):4820–4833. doi:10.1158/1078-0432.CCR-18-0205.
   PubMed Web of Science ®Google Scholar
• Nishiwaki N, Noma K, Ohara T, Kunitomo T, Kawasaki K, Akai M, Kobayashi T, Narusaka T, Kashima H, Sato H. et al. Overcoming cancer-associated fibroblast-induced immunosuppression by anti-interleukin-6 receptor antibody. Cancer Immunol Immunother. 2023;72(7):2029–2044. doi:10.1007/s00262-023-03378-7.
   PubMed Web of Science ®Google Scholar
• Kim JH, Oh SH, Kim EJ, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment. Biochem Biophys Res Commun. 2012;423(1):60–66. doi:10.1016/j.bbrc.2012.05.081.
   PubMed Web of Science ®Google Scholar
• Lin HJ, Liu Y, Caroland K, Lin J. Polarization of cancer-associated macrophages maneuver neoplastic attributes of pancreatic ductal adenocarcinoma. Cancers Basel. 2023;15(13):15. doi:10.3390/cancers15133507.
   Web of Science ®Google Scholar
• Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z. et al. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. 2017;8(13):20741–20750. doi:10.18632/oncotarget.15119.
   PubMedGoogle Scholar
• Ham IH, Oh HJ, Jin H, Bae CA, Jeon S-M, Choi KS, Son S-Y, Han S-U, Brekken RA, Lee D. et al. Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer. 2019;18(1):68. doi:10.1186/s12943-019-0972-8.
   PubMedGoogle Scholar